Grant ID RP140469
Awarded On August 20, 2014
Title Novel Small Molecule Probes Targeting IDH Mutated Glioma
Program Academic Research
Award Mechanism Individual Investigator
Institution/Organization Baylor College of Medicine
Principal Investigator/Program Director Yongcheng Song
Cancer Sites Brain and Other Nervous System
Contracted Amount $695,527
Lay Summary

Glioma is the most common form of brain tumors and can be classified into four grades at diagnosis. Grade I is a type of benign tumor. However, grades II and III gliomas are invasive, which can often progress to highly malignant, grade IV disease, i.e., secondary glioblastoma multiforme (GBM). Secondary GBM is a lethal disease with a median survival of 3.8 year as well as less than 10% 5-year survival rate for the patients. There is therefore a pressing need to find new therapeutics to treat gliomas. Isocitrate dehydrogenase (IDH) is one of the key enzymes in human metabolism. DNA sequencing of more than 1,000 human giloma samples has revealed that 75% of low-medium grade gliomas and seconda...

Read More